2021
|
Invention
|
Anti-podocalyxin antibodies and methods of using the same. The present invention is directed to a... |
2020
|
Invention
|
Anti-oncolytic virus antigen antibodies and methods of using same. e.ge.g., for therapeutic purpo... |
2019
|
Invention
|
Chelators and methods of making and using same. A chelating agent having the general formula (I) ... |
|
Invention
|
Anti-podocalyxin antibodies and methods of using the same. The present invention is directed to c... |
2018
|
Invention
|
Anti-hla-a2 antibodies and methods of using the same. Provided are humanized anti-HLA-A2 antibodi... |
|
Invention
|
Derivatized hyperbranched polyglycerols. 20 alkyl chains and a shell comprising at least one hydr... |
2016
|
Invention
|
Antibiotic compounds, pharmaceutical formulations thereof and methods and uses therefor.
The pre... |
|
Invention
|
Antibiotic compounds, pharmaceutical formulations thereof and methods and uses therefor. The pres... |
|
Invention
|
Compositions for promoting readthrough of premature termination codons, and methods of using the ... |
2015
|
Invention
|
Anti-bacterial pyruvate kinase modulator compounds, compositions, uses and methods. Compounds of ... |
2014
|
Invention
|
Matriptase variants associated with tumors. Described are variants of matriptase that are associa... |
|
Invention
|
Anti-podocalyxin antibodies and methods of using the same.
The present invention is directed to ... |
|
Invention
|
Mao-b selective inhibitor compounds, pharmaceutical compositions thereof and uses thereof. Descri... |
|
Invention
|
Resveratrol analogs and therapeutic uses thereof. Resveratrol analogs and their use to inhibit Kv... |
|
Invention
|
Cytotoxic and anti-mitotic compounds, and methods of using the same. Compounds having cytotoxic a... |
2011
|
Invention
|
Derivatized hyperbranched polyglycerols. Herein are provided derivatized hyperbranched polyglycer... |
|
G/S
|
Providing drug development expertise and infrastructure to enable researchers from academic and h... |